Patent intelligence · US
US 12006517
Method for purification of bacteriophage particles
Method for purification of bacteriophage particles
Patent details — US 12006517
- Jurisdiction
- US
- Status
- granted
- Grant date
- Jun 11, 2024
- Expiration
- Jun 6, 2044
- Applicant
- Adaptive Phage Therapeutics, Inc.
- Claims
- 19
- CPC classes
- A61K, A61K35/76, A61P, A61P31/04
Quick answer
US 12006517 (Method for purification of bacteriophage particles) is held by Adaptive Phage Therapeutics, Inc.. Status: granted. Granted Jun 11, 2024. Expires Jun 6, 2044 (18 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- Adaptive Phage Therapeutics, Inc.
- Grant date
- Expiration
- Claims
- 19
- CPC classes
- A61K, A61K35/76, A61P, A61P31/04
More from Adaptive Phage Therapeutics, Inc.
Related pharmaceutical patents in our USPTO index.
-
US 12264187
Compositions and methods for targeted therapeutic delivery to bone
granted -
US 12263179
Lyme disease-associated T cell receptor-related methods
granted -
US 12266425
T cell receptor sequences diagnostic for COVID-19 and related compositions
granted -
US 11911345
Phage dispensing system
granted -
US 11773138
Polypeptides including a beta-tricalcium phosphate-binding sequence and uses thereof
granted -
US 11390921
Determining WT-1 specific T cells and WT-1 specific T cell receptors (TCRs)
granted -
US 11192923
Polypeptides including a beta-tricalcium phosphate-binding sequence and uses thereof
granted
Frequently asked questions
What is US patent 12006517?
US 12006517 (Method for purification of bacteriophage particles) is held by Adaptive Phage Therapeutics, Inc.. Status: granted. Granted Jun 11, 2024. Expires Jun 6, 2044 (18 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 12006517?
Adaptive Phage Therapeutics, Inc. is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 12 pharmaceutical patents for this assignee.
When does US 12006517 expire?
Our index shows an expiration date of Jun 6, 2044 (18 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.